Empirical Financial Services LLC d.b.a. Empirical Wealth Management lessened its position in Danaher Corporation (NYSE:DHR – Free Report) by 14.2% in the 1st quarter, Holdings Channel reports. The firm owned 18,188 shares of the conglomerate’s stock after selling 3,013 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management’s holdings in Danaher were worth $3,448,000 at the end of the most recent quarter.
Several other hedge funds also recently bought and sold shares of DHR. State Street Corp grew its holdings in shares of Danaher by 1.7% in the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock valued at $6,345,529,000 after buying an additional 472,608 shares during the period. Capital International Investors raised its stake in Danaher by 8.9% during the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after buying an additional 1,487,768 shares during the period. Price T Rowe Associates Inc. MD raised its stake in Danaher by 9.1% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock worth $3,656,595,000 after buying an additional 1,334,221 shares during the period. Wellington Management Group LLP lifted its holdings in Danaher by 11.2% during the fourth quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock worth $3,451,380,000 after acquiring an additional 1,517,904 shares in the last quarter. Finally, Norges Bank bought a new position in Danaher during the fourth quarter worth about $2,177,106,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.
Danaher Stock Performance
Shares of Danaher stock opened at $199.06 on Wednesday. The firm has a market cap of $140.89 billion, a price-to-earnings ratio of 38.50, a price-to-earnings-growth ratio of 2.55 and a beta of 0.79. The stock’s 50-day moving average is $181.51 and its 200-day moving average is $198.83. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52.
Danaher Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.8%. Danaher’s dividend payout ratio is 30.95%.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on the company. JPMorgan Chase & Co. lowered their price target on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Jefferies Financial Group reiterated a “buy” rating and set a $245.00 price objective on shares of Danaher in a report on Tuesday, April 21st. HSBC decreased their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Wells Fargo & Company lowered their target price on Danaher from $240.00 to $212.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 22nd. Finally, The Goldman Sachs Group dropped their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a report on Monday, April 13th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $231.64.
Read Our Latest Stock Report on DHR
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Stories
- Five stocks we like better than Danaher
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
- 3 Overlooked Energy ETFs Delivering Strong Returns and Income
- 3 Space Stocks That Could Outshine SpaceX After Its IPO
- JPMorgan’s Q2 Strength Gives the Stock Rally New Support
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
